Targeting Akt signaling in breast cancer : expression of phosphorylated Akt in breast tumors and the efficacy of celecoxib analogues as potential inhibitors of Akt activation
Constitutive activation of Akt, due to overexpression of receptor tyrosine kinases (RTKs) or loss of phosphatase and tensin homologue (PTEN), contributes to the development of breast cancer and confers resistance to conventional therapies. Therefore, the Akt signaling pathway is an attractive tar...
Main Author: | Kucab, Jill |
---|---|
Format: | Others |
Language: | English |
Published: |
2009
|
Online Access: | http://hdl.handle.net/2429/16264 |
Similar Items
-
Oridonin, an AKT1 Inhibitor, Suppresses the Growth of Breast Cancers with Hyperactivation of PI3K/AKT Signaling
by: Liu Xin-Yu, et al.
Published: (2021-01-01) -
Molecular Targets of Breast Cancer: AKTing in Concert
by: Alakananda Basu
Published: (2008-01-01) -
Dichotomy effects of Akt signaling in breast cancer
by: Peng Zhengang, et al.
Published: (2012-08-01) -
Dichotomy effects of Akt signaling in breast cancer
by: Peng, Zhengang, et al.
Published: (2012) -
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
by: Federica Martorana, et al.
Published: (2021-04-01)